| Literature DB >> 25057467 |
E M Meintjes1, K L Narr2, A J W van der Kouwe3, C D Molteno4, T Pirnia2, B Gutman5, R P Woods2, P M Thompson5, J L Jacobson6, S W Jacobson6.
Abstract
Reductions in brain volumes represent a neurobiological signature of fetal alcohol spectrum disorders (FASD). Less clear is how regional brain tissue reductions differ after normalizing for brain size differences linked with FASD and whether these profiles can predict the degree of prenatal exposure to alcohol. To examine associations of regional brain tissue excesses/deficits with degree of prenatal alcohol exposure and diagnosis with and without correction for overall brain volume, tensor-based morphometry (TBM) methods were applied to structural imaging data from a well-characterized, demographically homogeneous sample of children diagnosed with FASD (n = 39, 9.6-11.0 years) and controls (n = 16, 9.5-11.0 years). Degree of prenatal alcohol exposure was significantly associated with regionally pervasive brain tissue reductions in: (1) the thalamus, midbrain, and ventromedial frontal lobe, (2) the superior cerebellum and inferior occipital lobe, (3) the dorsolateral frontal cortex, and (4) the precuneus and superior parietal lobule. When overall brain size was factored out of the analysis on a subject-by-subject basis, no regions showed significant associations with alcohol exposure. FASD diagnosis was associated with a similar deformation pattern, but few of the regions survived FDR correction. In data-driven independent component analyses (ICA) regional brain tissue deformations successfully distinguished individuals based on extent of prenatal alcohol exposure and to a lesser degree, diagnosis. The greater sensitivity of the continuous measure of alcohol exposure compared with the categorical diagnosis across diverse brain regions underscores the dose dependence of these effects. The ICA results illustrate that profiles of brain tissue alterations may be a useful indicator of prenatal alcohol exposure when reliable historical data are not available and facial features are not apparent.Entities:
Keywords: AA, absolute alcohol; Brain structure; CSF, cerebrospinal fluid; FAS, fetal alcohol syndrome; FASD, fetal alcohol spectrum disorders; Fetal alcohol spectrum disorders; ICA, independent component analyses; MDT, minimal deformation target; MEMPRAGE, multiecho magnetization prepared rapid gradient echo; Morphology; Neurodevelopment; Prenatal alcohol exposure; Structural MRI; TBM, tensor-based morphometry; Tensor-based morphometry; WISC-IV, Wechsler Intelligence Scale for Children
Mesh:
Year: 2014 PMID: 25057467 PMCID: PMC4097000 DOI: 10.1016/j.nicl.2014.04.001
Source DB: PubMed Journal: Neuroimage Clin ISSN: 2213-1582 Impact factor: 4.881
Sample characteristics by diagnostic group (N = 55).
| FAS | PFAS | HE | Control | ||
|---|---|---|---|---|---|
| (7) | (18) | (14) | (16) | ||
| Maternal/primary caregiver characteristics | |||||
| Age at delivery | 30.6 (9.1) | 26.5 (6.9) | 24.7 (5.4) | 27.1 (4.2) | 1.70 |
| Years of education | 9.3 (2.4) | 6.5 (2.4) | 9.2 (2.2) | 10.1 (1.4) | 9.41 |
| Married (%) | 42.9 | 27.8 | 42.9 | 62.5 | 4.16 |
| Parity | 3.1 (1.4) | 2.6 (1.9) | 1.9 (0.8) | 1.8 (0.9) | 2.50 |
| Alcohol during pregnancy | |||||
| oz AA/day | 1.9 (2.6) | 1.0 (0.7) | 0.5 (0.5) | 0.01 (0.03) | 6.38 |
| oz AA/occasion | 4.2 (2.6) | 3.8 (1.8) | 2.8 (1.6) | 0.2 (0.5) | 17.82 |
| Frequency (days/week) | 2.1 (2.2) | 2.0 (1.0) | 1.1 (0.9) | 0.04 (0.1) | 11.12 |
| Cigarettes/day during pregnancy | |||||
| 9.5 (5.1) | 8.2 (5.9) | 8.4 (7.3) | 3.7 (9.9) | 1.57 | |
| Child characteristics | |||||
| Child gender (% male) | 28.6 | 61.1 | 57.1 | 43.8 | 2.69 |
| Age | |||||
| Neurobehavioral assessment (years) | 9.1 (0.3) | 9.4 (0.4) | 9.6 (0.5) | 9.3 (0.4) | 2.85 |
| Neuroimaging scan (years) | 10.0 (0.5) | 10.6 (0.4) | 10.6 (0.2) | 10.3 (0.4) | 4.84 |
| Weight (kg) | 21.3 (2.7) | 25.9 (2.8) | 37.6 (16.1) | 29.5 (6.8) | 6.43 |
| Height (cm) | 120.8 (3.9) | 128.4 (5.0) | 136.4 (10.0) | 129.7 (5.8) | 8.89 |
| Head circumference (cm) | 49.6 (2.0) | 50.7 (1.6) | 52.6 (1.7) | 52.6 (1.0) | 9.89 |
| WISC-IV IQ | 65.0 (8.7) | 63.6 (10.3) | 72.8 (8.2) | 74.8 (8.1) | 5.65 |
| Volumetric measures (cm3) | |||||
| Total intracranial volume | 1223 (127) | 1340 (122) | 1435 (126) | 1359 (86) | 5.50 |
Values are mean (SD) or %. FAS = fetal alcohol syndrome, PFAS = partial FAS, HE = heavily exposed nonsyndromal.
Obtained from mother or primary caregiver at 9-year follow-up assessment visits.
p < 0.10.
p < 0.05.
p < 0.01.
p < 0.001.
Fig. 1Relation of total brain volume to Jacobian values averaged across the entire brain in unscaled / native (left) and normalized / scaled (right) space for each subject. FASD = fetal alcohol spectrum disorders.
Fig. 2Statistical maps relating the degree of prenatal alcohol exposure to local brain tissue differences in unscaled data, adjusted for child sex. Top: color encoded r -values showing the relations between oz absolute alcohol (AA) / day and regional brain tis- sue reductions (hot colors) and expansions (cool colors). 1 oz AA ≈2 standard drinks. Bottom: significant effects of oz AA / day shown in corresponding slice views in red (uncorrected p < .05), and effects surviving an FDR threshold of q = .05 super- imposed in yellow. Right: mean Jacobian values from each subject, masked to include only regions where the uncorrected p value for AA / day was < .05, plotted as a function of oz AA / day during pregnancy.
Fig. 3Statistical maps relating the degree of prenatal alcohol exposure to local brain tissue differences in scaled data, adjusted for child sex. Top: color encoded r -values showing the relation between oz absolute alcohol (AA) / day and regional brain tissue reductions (hot colors) and expansions (cool colors). Bottom: significant effects of oz AA / day shown in corresponding slice views in red (uncorrected p < .05). Effects did not survive FDR thresholding at q = .05 at any brain location. Right: mean Jacobian values from each subject, masked to include only regions where the uncorrected p value for AA / day was < .05, plotted as a function of oz AA / day during pregnancy.
Fig. 4Statistical maps showing the effects of diagnosis (fetal alcohol syndrome (FAS) and partial FAS (pFAS) compared to controls) on regional brain tissue volumes in un- scaled data, adjusted for child sex. Top: color encoded beta -values showing the effects of diagnosis on FASD-related regional brain tissue reductions (hot colors) and expan- sions (cool colors). Bottom: significant effects of diagnosis are shown in corresponding slice views in red (uncorrected p < .05), and p -values surviving FDR correction ( q = .05) are superimposed in yellow. Right: mean Jacobian values from each subject, masked to include only regions where the uncorrected p value for an effect of diagnosis was < .05, plotted by diagnostic status.
Fig. 5Group differences on corrected putamen (p = .005) and hippocampus (p < .001) volumes between participants with spina bifida myelomeningocele (SBM; n = 48) and typically developing controls (TD; n = 18). Values reflect averages between left and right hemispheres. Note: bars represent standard error.